Tag: NPT TRI

Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health

Injectable Offers Potential to Reduce Fatty Liver Diseases and Improve Health Markers in AdultsNEW ORLEANS, June 7, 2026 /PRNewswire/ -- New data highlight the potential...

Solve M.E. Selects Simmaron Research As Recipient of ME/CFS Catalyst Award to Accelerate Low-Dose Rapamycin Trial for ME/CFS, Long COVID, and IACCs

The Catalyst Award will expedite the hunt for a validated test-to-treat model for ME/CFS, a disease for which there is currently no FDA-approved treatment. LOS...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsNPT TRI

EpiCooler Product Information Updated As Consumer Interest In Portable AC Grows In 2026

Building the AI-First Gulf: How GCC Enterprises Are Entering the Next Digital Era

SPCL 成为 SpaceX 上市首日首个且唯一提供 2 倍杠杆风险敞口的美国 ETF

Tag: NPT TRI

Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health

Solve M.E. Selects Simmaron Research As Recipient of ME/CFS Catalyst Award to Accelerate Low-Dose Rapamycin Trial for ME/CFS, Long COVID, and IACCs

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us